QALSODY
NDC 64406-109, tofersen, injection, from Biogen Inc..
- Product NDC
- 64406-109
- Status
- Listed
- Labeler
- Biogen Inc.
- Dosage form
- INJECTION
- Route
- INTRATHECAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215887
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64406-109 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFERSEN100 mg/15mL
Pharmacologic classes
Antisense Oligonucleotide [EPC]; Oligonucleotides, Antisense [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64406-109-01 | 64406010901 | 1 VIAL, SINGLE-USE in 1 CARTON (64406-109-01) / 15 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/81356b45-1cb7-4eef-88ea-e44cc18b47c5Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=64406-109
Use it
Look up 64406-109 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64406-109 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64406-109. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.